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Aim: To produce mammalian biomimetic nanosponges from mammalian erythrocyte 
ghosts. Biomimetic nanosponges were studied in vitro as treatment platforms against 
exotoxin-related sepsis. Methods: Ovine blood was treated with hypotonic buffer to 
create erythrocyte ghosts and then subjected to sonication to produce erythrocyte 
vesicles of nonuniform size. Vesicles were then serially extruded through 400-nm 
and 100-nm polycarbonate membranes. Nanosponges were prepared by fusing 
poly( d , l -lactic-co-glycolic acid) cores with ovine erythrocyte vesicles. Results: Ovine 
erythrocytes were the most susceptible to streptolysin-O lysis, making it a model to 
study sepsis treatment. Ovine nanosponges adsorbed streptolysin-O at 37 and 40°C. 
Conclusion: These results identify ovine nanosponges as novel therapeutic model to 
test adsorption of cholesterol binding toxins such as streptolysin-O.
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Bacteria can invade and destroy human cells 
due to virulence factors known as endotoxins 
and exotoxins. These virulence factors cause 
a condition known as sepsis (systemic inflam-
matory response syndrome), which is a whole 
body inflammation. Severe sepsis (organ dys-
function) or septic shock (abnormally low 
blood pressure and organ damage) is a major 
public health problem in England [1]. From 
2001 to 2010, there were 226,547 associ-
ated deaths. About 50% of sepsis cases can 
be attributed to bacterial pathogens [2]. Sep-
sis was observed to be directly related to age 
with a positive correlation between increas-
ing numbers of deaths and age. To reduce the 
mortality rate caused by sepsis, there has to 
be an improvement in treatment.
Common toxins associated with sepsis 
are pore-forming toxins (PFTs). PFTs are 
proteins released by bacteria that are widely 
distributed and form lesions in the host cel-
lular membrane. The toxins found to be 
most potent are α-hemolysin and strepto-
lysin-O. α-hemolysin is released by Staphylo­
coccus aureus and streptolysin-O is released 
by Streptococcus pyogenes [3]. These toxins are 
released in the blood stream of an infected 
patient and bind to a variety of cells includ-
ing red blood cells (RBCs) and cause them to 
hemolyze [4].
Mechanism of PFT binding
The principal function of pore-forming tox-
ins is to disrupt host cell membranes. This 
function is carried out to kill target cells, 
to release nutrients and, at times, delivery 
of bacterial or external factors. Loss of this 
function could cause the pathogenic strain 
to become less virulent. PFTs are generally 
secreted as a water soluble monomer. These 
toxins tend to be specific for cellular tar-
gets on cellular membranes; upon recogni-
tion they bind to the receptor and undergo 
conformational change, which leads to a 
Development of nanosponges from 
erythrocyte ghosts for removal of 
streptolysin-O from mammalian blood
Vikesh Chhabria1 & 
Steve Beeton*,1
1School of Pharmacy & Biomedical 
Sciences, University of Central 
Lancashire, Preston, Lancashire, PR1 2HE, 
UK 
*Author for correspondence:  
sbeeton@uclan.ac.uk
SPECIAL FOCUS y Functional nanomaterials in industrial applications
For reprint orders, please contact: reprints@futuremedicine.com
2798 Nanomedicine (Lond.) (2016) 11(21) future science group
Research Article    Chhabria & Beeton
pore spanning across the membrane [1]. There are two 
families of PFTs, classified according to their second-
ary structure. There are α-PFTs and β-PFTs; majority 
of PFTs are of the β-family of toxins [5]. Toxins bind 
to various targets on the cellular membrane, some are 
specific for proteins such as α-hemolysin and the other 
bind to lipids on the membrane (Figure 1). One such 
example is a group that falls under the β-PFTs, known 
as cholesterol-dependent cytolysins. An example of 
this type of PFTs is streptolysin-O. This toxin binds to 
cholesterol embedded in lipid bilayers present in some 
mammalian cells [6].
Current treatment & application of 
nanosponges
Treatment options for sepsis include antibiotics, surgi-
cal drainage of infected fluids, blood transfusion, organ 
replacement and steroids. Most of these treatment strat-
egies reduce the inflammatory response [7]. The first-
line treatment would be intravenous administration of 
antibiotics. However, due to the high rates of antibi-
otic resistance, sepsis and other fatal conditions caused 
by these bacteria are becoming difficult to treat [8]. 
Therefore, this research aims to synthesize a biomi-
metic biosponge known as a ‘nanosponge’ that has the 
ability to absorb PFTs and therefore, in turn, could 
reduce the incidence and severity of exotoxin-related 
sepsis. Nanosponges are a nanoparticle constructed 
with a polymeric core (poly[ d , l -lactic-co-glycolic acid] 
[PLGA]) enveloped by, in this case, RBC membranes. 
Each component of the nanosponge has a significant 
property. The RBC membrane contains surface prop-
erties that allow absorption of PFTs. Its highly flexible 
structure enables it to pass through narrow capillary 
networks [9]. By coating it with a mammalian erythro-
cyte membrane, the nanosponge is nonimmunogenic 
even if released back into the same mammalian species.
Materials & methods
All chemicals were analytical grade and purchased 
from Fisher Scientific UK Ltd (Loughborough, UK), 
Sigma-Aldrich Ltd (Dorset, UK), Diagnostic Reagents 
Ltd (Oxfordshire, UK) and Electron Microscopy Sci-
ences (PA, USA). Ovine and porcine blood was col-
lected from an abattoir (William Taylor and Sons, 
Lancashire, UK). Murine blood was collected from 
the university of Central Lancashire Laboratory (Lan-
cashire, UK). Leporine blood was purchased from TCS 
biosciences (Botolph claydon, Buckingham, UK).
Development & characterization of ovine 
erythrocyte ghosts
Erythrocyte ghosts were produced using a ghosting 
protocol [10]. Erythrocytes were washed three-times 
with isotonic (pH 7.2) phosphate buffered saline 
(PBS) and centrifuged at 500 × g to produce a concen-
trated erythrocyte suspension. The washing allowed 
removal of the buffy coat (platelets and white blood 
cells) and plasma. This erythrocyte suspension was 
subjected to hypotonic lysis, which allowed the release 
of free cellular hemoglobin (Hb) from the erythro-
cyte. The lysed erythrocyte suspension was left on ice 
for 20 min. The suspension was then centrifuged at 
22,000 × g for 10 min at 4°C. The Hb present in the 
supernatant was washed with isotonic PBS and then 
recentrifuged at 22,000 × g for 10 min. A pink pel-
let was formed at the end of the tube, which was the 
erythrocyte ghosts. The erythrocyte ghosts have the 
property to reseal; however, the reason is unknown. 
The resealed erythrocyte ghosts were collected and 
examined using a previously published scanning 
electron microscopy protocol with slight modifica-
tions [11]. The modifications to the protocol were the 
concentration of the fixatives used and the duration 
of fixation. The erythrocyte ghosts were fixed in 3% 
g lutaraldehyde for 3 h and then in 2% osmium tetrox-
ide for 2 h. The dried pellet was fixed onto a carbon 
stub and coated with gold. The ovine erythrocyte 
ghosts were observed under a Quanta 200 scanning 
electron microscope (OR, USA).
Synthesis of ovine erythrocyte vesicles
The ovine erythrocyte ghosts were reconstituted in 
3 ml of isotonic PBS (pH 7.2) and sonicated using 
a VWR (Leicestershire, England) sonicating water 
bath (50–60 Hz) for 20 min to produce erythrocyte 
vesicles of nonuniform size (1.0–2.1 μm). The result-
ing vesicles were serially extruded through a 400-nm 
and then a 100-nm polycarbonate membrane 13-times 
at 20°C (Figure 2), using a Avestin lipofast extruder 
(Weinheimer, Mannheim, Germany), which devel-
oped vesicles of uniform size (Figure 3B). The erythro-
cyte vesicles were characterized for size and polydisper-
sity in isotonic PBS (pH 7.2) at 37°C using a Malvern 
Nano-zs zetasizer (Malvern, Worcestershire, UK) [12].
Production of PLGA polymeric core
The PLGA polymeric cores were prepared using a sol-
vent displacement process [13]. About 1 ml of a 1 mg/
ml PLGA solution was prepared in acetone (organic 
solvent) and added dropwise to 3 ml of distilled water. 
This solution was stirred for 4 h at 20°C to allow the 
organic phase to evaporate. The prepared PLGA cores 
were precipitated using a Merck Millipore filter with a 
10-kDa molecular weight cutoff. The PLGA cores were 
washed three-times with isotonic PBS to filter out the 
organic solvent. The precipitated PLGA  nanoparticles 
were reconstituted in 1 ml PBS.
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Figure 1. Mechanisms of pore formation by pore-forming exotoxins. Diagrammatic representation of pore formation. Pore-
forming exotoxins (PFTs), specific for certain receptors, recognize the target site on the membrane, which are either lipids 
(phosphatidylcholine, cholesterol and sphingomyelin) or proteins (ADAM 10). Upon binding the toxin starts oligomerizing. For β-PFTs, 
oligomerization occurs on the surface of the membrane producing a structure known as a prepore, which eventually produces a pore 
that spans across the membrane. β-PFTs like streptolysin-O (cholesterol-dependent cytolysin) have high affinity toward the lipid raft 
domain embedded in cholesterol. Another β-PFTs α-hemolysin is specific for a protein known as ADAM 10 and also a phospholipid 
group called phosphatidylcholine.
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Synthesis of nanosponges
The erythrocyte vesicles and the PLGA polymeric cores 
were added in equal volumes and extruded 13-times 
through a 100-nm polycarbonate membrane at 20°C. 
The mechanical force of extrusion allowed fusion of 
the erythrocyte vesicles with the PLGA nanoparticle, 
synthesizing a nanoparticle with a lipid coating and a 
PLGA polymeric core [12]. Nanosponges were charac-
terized using standard operating protocols [9]. Nano-
sponges (1 mg/ml) were characterized for size and 
polydispersity in isotonic PBS (pH 7.2) at 37°C using a 
Malvern Nano-zs zetasizer.
Toxin lysis assay
Streptolysin-O was assayed for hemolysis against four 
different species of mammalian blood (porcine, lepo-
rine, ovine and murine). Parameters were selected on 
the basis of a recent publication, with modifications [3]. 
Increasing concentrations of streptolysin-O were 
added to a 500 μl 2% (v/v) erythrocyte suspension. 
2800 Nanomedicine (Lond.) (2016) 11(21)
Figure 2. Mechanism of extrusion. A diagrammatic representation of sonicated vesicles being extruded through 
a 100-nm polycarbonate membrane. The vesicles are extruded using the mechanical force generated by the push 
of the syringe. This mechanical energy forces the vesicles through the 100-nm membrane synthesizing vesicles of 
uniform size.
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The mixed suspension containing toxin and erythro-
cytes were incubated at 37°C for 30 min. These 
were then centrifuged and 20 μl of the supernatant 
was added to 4 ml of Drabkins reagent (Diagnostic 
reagents Ltd, Oxfordshire, UK). The optical density 
was then recorded at 540 nm using a Jenway spectro-
photometer (Bibby Scientific Ltd, Staffordshire, UK). 
The Hb was estimated using a bovine Hb standard 
curve (Supplementary Figure 1). The concentration 
of Hb released was represented as a percentage of the 
total Hb present in a 2% (v/v) erythrocyte suspen-
sion, as the Hb concentration differs between animals. 
The assay has a detection range between 250 and 
0.2 mg/ml streptolysin-O. The Drabkins reagent also 
had a  detection range of 0.01–11.2 g/dl.
Toxin absorption assays
Testing the efficacy of erythrocyte ghosts as a 
toxin-absorbing system
Absorption of streptolysin-O by erythrocyte ghosts 
was tested using a novel assay. Washed ovine blood 
was diluted to make a 2% (v/v) erythrocyte suspen-
sion, 2% (v/v) erythrocyte ghost suspension and a 2% 
(v/v) mixed (ghosts and erythrocytes) RBC suspension 
(Supplementary Figure 2). The 2% erythrocyte ghost 
suspension was made by adding 2 parts of washed 










). This buffer was used to lyse erythrocytes 
to synthesize the erythrocyte ghosts. The erythrocyte 
ghost pellet was washed three-times with isotonic PBS 
and then reconstituted in it. The 2% mixed erythro-
cyte suspension was made by adding one part of the 2% 
erythrocyte suspension to one part of the 2% erythro-
cyte ghost suspension. About 1230 ng/ml (estimated 
human physiological concentration) of streptolysin-O 
was added to the three suspensions and incubated in a 
water bath at 37°C for 30 min. The suspensions were 
then centrifuged for 5 min at 900 × g in an Eppen-
dorf 540R microcentrifuge (Arlington business park, 
Stevenage, UK) at 4°C. The concentration of Hb 
was measured by adding 20 μl of the supernatant to 
4 ml  Drabkins reagent and the solution was allowed 
to stand for 15 min. The optical density was read at 
540 nm (Hb A). About 250 μl of the supernatant was 
aspirated from each system and added to a separate 
2% RBC suspension, which was incubated for 30 min 
at 37°C. The tubes were then centrifuged at 4°C for 
5 min at 900 × g. About 20 μl of the supernatant is 
added to 4 ml of Drabkins reagent and was allowed 
to stand for 15 min. The optical density was then read 
at 540 nm (Hb B). The concentration of Hb released 
by unbound toxin was measured by subtracting Hb A 
from Hb B. This procedure was repeated with 0.1% 
Triton™ X-100 (v/v) from Sigma-Aldrich (Dorset, 
UK) as a positive control.
Testing the efficacy of nanosponges as a toxin-
absorbing system
Toxin absorption by nanosponges was tested using a 
published method [9]. This method was optimized to 
achieve desired experimental conditions. About 50 μl 
of a 1230 ng/ml (sheep physiological concentration at 
which 50% of the erythrocytes were lysed) streptolysin-
O solution was added to four test systems: streptolysin-
O and 2% erythrocyte suspension; streptolysin-O, 
erythrocyte vesicles and 2% erythrocyte suspension; 
streptolysin-O, PLGA polymer and 2% erythrocyte 
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suspension; and streptolysin-O, ovine nanosponges 
and 2% erythrocyte suspension. The total volume in 
these four different systems was 550 μl. These four sys-
tems were then incubated at 37 and 40°C which emu-
lated the elevated body temperature during sepsis [14]. 
The suspensions were then centrifuged for 5 min at 
900 × g. About 20 μl of the supernatant was added 
to 4 ml of Drabkins reagent and allowed to stand for 
15 min. The optical density was then read at 540 nm.
Statistical analysis
Significance denoted, by an asterisk, was determined 
by a paired t-test using SPSS 22.0 (IBM, Portsmouth, 
UK).
Results
Morphology of porcine erythrocytes & ghosts
The erythrocyte ghosts were characterized using scan-
ning electron microscopy. The erythrocyte ghost pellet 
was fixed in 3% glutaraldehyde followed by fixation in 
2% osmium tetroxide (Supplementary Figure 3).
Characterization of ovine erythrocyte vesicles
The nanosponges were synthesized by fusing the PLGA 
core with the erythrocyte vesicles. Prior to fusion, the 
erythrocyte vesicles were measured for size and poly-
dispersity. The vesicles were produced by sonication 
followed by extrusion through 400- and 100-nm poly-
carbonate membranes. Sonication times did have a 
significant impact on polydispersity index (PDI) and 
size of the erythrocyte vesicles. Vesicles sonicated for 
21 min had a PDI of 0.78 (± 0.04) compared with ves-
icles sonicated for 14 min, which had a PDI of 0.33 (± 
0.04) (Figure 3A). Vesicles sonicated for 21 min had a 
smaller average size of 1041 (± 445) nm compared with 
vesicles sonicated for 14 min (Figure 3B). Sonicated ves-
icles were serially extruded, which decreased the PDI 
to 0.13 (± 0.01) (Figure 3A) and the size to 181 (± 39) 
nm (Figure 3B). The nanosponges were also character-
ized using dynamic light scattering (DLS) for size and 
PDI (Supplementary Figure 4). The nanosponges had 
a size of 185 nm (± 5.0) with a PDI of 0.134 and a 
ζ potential of -10.5 mV (± 7.4).
Streptolysin-O hemolytic assay
Streptolysin-O was assayed against four different spe-
cies of mammalian blood. A 2% (v/v) erythrocyte 
suspension was prepared, to which increasing concen-
trations of streptolysin-O were added. The suspen-
sions were incubated at 37°C for 30 min. The suspen-
sions were then centrifuged and the supernatant was 
read for Hb concentration at 540 nm. The measured 
Hb was estimated using a bovine Hb standard curve 
(Supplementary Figure 1). Since each animal blood has 
a different amount of Hb present in their system, hemo-
lysis was calculated as a percentage of the total amount 
of Hb present in a 2% erythrocyte suspension. Accord-
ing to Figure 4, at high concentrations of streptolysin-
O, the 2% ovine erythrocyte suspension was most sus-
ceptible to lysis by streptolysin-O toxin as 2000 ng/ml 
streptolysin-O released 80.08% (± 1.40) Hb compared 
with the other species of blood. At lower concentrations 
of streptolysin-O (250–1250 ng/ml), murine erythro-
cytes are more susceptible to  streptolysin-O lysis, 
 compared with ovine erythrocytes.
Streptolysin-O absorption assays
Streptolysin-O absorption was tested across lipid and 
polymeric systems which when fused via extrusion 
developed into nanosponges. Figure 5A shows that 
ovine erythrocyte ghosts had the ability to absorb 
streptolysin-O. This test involved the addition of 
supernatant containing unbound toxin to a 2% eryth-
rocyte suspension. This was indicated by the degree of 
hemolysis. The system that contained 2% ovine RBC 
had the highest concentration of Hb release at 0.45 g/
dl (± 0.05) compared with the system that contained 
2% ghosts, which had the least Hb release at 0.30 g/
dl (± 0.03). The system that contained a mixture 
of the ovine RBC and the ghost had nearly half the 
Hb release of the 2% ovine RBC system (0.36 g/dl, 
± 0.03). These results were compared with a positive 
control, which involved the addition of 0.1% Triton 
X-100 to the three different suspensions. This suspen-
sion has the ability to solubilize lipids, thereby releas-
ing maximum amount of Hb from the erythrocytes 
and ghosts.
The ovine erythrocyte ghosts were sonicated to pro-
duce vesicles, which were extruded with the PLGA 
polymer to produce nanosponges. Figure 5B shows 
the efficacy of the nanosponge and its components 
to absorb streptolysin-O. This was tested by adding 
the streptolysin-O and 2% RBC to systems contain-
ing the PLGA polymer, vesicles and nanosponges, 
which were incubated at 37°C for 30 min. Absorp-
tion was measured by concentration of Hb release 
(Supplementary Figure 5). The system that contained 
the nanosponges had the least Hb release at 0.005 g/
dl (± 0.005) compared with the system containing just 
the toxin and erythrocytes (0.23 g/dl, ± 0.01). The 
system that contained the vesicles was able to absorb 
the toxins similar to the ovine erythrocyte ghosts in 
the previous test, as it had nearly half the Hb release 
(0.08 g/dl, ± 0.01), as opposed to the system contain-
ing just toxin and erythrocytes. A similar result was 
achieved when the four different systems were incu-
bated at 40°C (estimated human body temperature 
during  sepsis) as shown in Figure 5C.
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Figure 3. Characterization of ovine erythrocyte vesicles by measuring the size and polydispersity index using 
dynamic light scattering. (A) Measurement of polydispersity index of erythrocyte vesicles, which were sonicated 
for 7, 14 and 21 min followed by 400 and 100 nm extrusion. (B) Estimation of the size of erythrocyte vesicles that 
were sonicated for 7,14 and 21 min followed by 400- and 100-nm extrusion. The ovine erythrocyte vesicles were 
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The nanosponge and its components were lyophi-
lized in 5% sucrose and stored at 2–4°C for 1 week. 
The nanosponge and its components were then recon-
stituted with PBS and tested for their efficacy to 
adsorb streptolysin-O (Figure 5D). Similar to the previ-
ous results the system that contained the nanosponge 
shows the least Hb release at 0.05 g/dl (± 0.04).
Nanosponge dose-dependent assay
The ovine nanosponges (1 mg/ml) were added in 
increasing concentration to systems that contained 
2% ovine erythrocytes and 1230 ng/ml streptolysin-
O. The mixed suspensions were incubated at 40°C for 
30 min. The suspensions were then centrifuged and 
the supernatant was measured for concentration of Hb 
released. According to Figure 6, 10,000 ng/ml nano-
sponge absorbed 1230 ng/ml streptolysin-O as the 
concentration of Hb released is minimal (0.009 g/dl, 
± 0.005). Comparatively, 2000 ng/ml nanosponge had 
the highest concentration of Hb released at 0.554 g/dl 
(± 0.03).
Discussion
The overall aim of the research was to study the 
adsorption of a bacterial PFT by previously developed 
biomimetic nanosponges [9], under temperature con-
ditions that mimic sepsis in humans [14]. This study 
was conducted using ovine blood as an animal model. 
Previous studies have reported using ovine systems as 
a model for endotoxin-derived sepsis, as their blood 
components are similar to that of humans and they 
have similar physiological parameters [15]. All the 
experiments conducted in this study to prove toxin 
adsorption involve measurement of Hb released.
Characterization of ovine erythrocyte 
vesicles
The nanosponges were synthesized by fusing the 
PLGA core with erythrocyte vesicles. The ovine 
erythrocyte vesicles were characterized using two 
parameters (PDI and size) measured by the principles 
of dynamic light scattering. Sonication and extrusion 
were used to assess homogeneity among the vesicles. 
Figure 3A showed that sonication after 21 min devel-
oped polydispersed particles (PDI = 0.78); however, 
vesicles sonicated for 21 min had a smaller average size 
of 1041 nm (Figure 3B). Extrusion of ovine erythro-
cyte vesicles produced homogeneous vesicles with a 
PDI of 0.13 and an average size of 181 nm (Figure 3B). 
Assessing homogeneity and size is significant as eryth-
rocytes travel through capillaries and sinusoids. If the 
particle size is too large, this could lead to aggrega-
tion [16]. This will cause the erythrocyte vesicles to 
lose its function as a biomimetic nanoparticle. Reduc-
tion in size of ovine vesicles, due to extrusion and 
longer sonication times, was significant as it increases 
the surface area to volume ratio of the nanosponges 
(Supplementary Figure 6). Higher surface area to 
volume ratio leads to a higher rate of toxin adsorp-
tion [17]. Compared with ovine erythrocytes (3.6 μm), 
the size of the nanosponge was recorded as 185 nm 
(Supplementary Figures 4 & 7). The surface area to 
volume ratio of ovine nanosponges is 19-times higher 
than ovine erythrocytes, which means that the ovine 
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Figure 4. The effect of streptolysin-O on hemoglobin release from four different types of mammalian erythrocyte 
suspensions. Increasing concentrations of streptolysin-O were added to a 2% erythrocyte suspension made from 
leporine (rabbit ), murine (rat ▪), porcine (pig ) and ovine (sheep •) blood. Total hemoglobin present in a 2% 
erythrocyte suspension: leporine (2.67 g/dl, ± 0.07), murine (1.87 g/dl, ± 0.07), ovine (1.43 g/dl, ± 0.09) and porcine 
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nanosponges will have more surface area than volume 
to adsorb streptolysin-O.
Streptolysin-O hemolytic assay
This study investigated the degree of streptolysin-O 
hemolysis against ovine, porcine, leporine and murine 
erythrocytes. Streptolysin-O is a pore-forming toxin 
secreted by group A streptococcus and is shown to bind 
specifically to cholesterol on the erythrocyte mem-
brane [18]. Figure 4 showed that streptolysin-O was 
highly sensitive toward ovine erythrocytes, as 2000 ng/
ml of streptolysin-O released 80.08% (±1.40) ovine Hb 
compared with other species of blood. According to a 
previously published study, ovine erythrocytes had a 
higher concentration of cholesterol present in the mem-
brane [19]. At lower concentrations of streptolysin-O 
(250–1250 ng/ml), murine erythrocytes are more sus-
ceptible to streptolysin-O lysis, compared with ovine 
erythrocytes. The reason for this is unknown. Further 
tests may need to be employed in order to verify this 
result. This study suggested that ovine erythrocytes 
can be used as an animal model to develop biomi-
metic nanosponges as they showed the highest affin-
ity toward streptolysin-O attack. An animal model has 
many advantages as it could aid in the development 
of new therapeutic platform; animal systems could be 
easily manipulated to achieve physiological conditions 
similar to that of human; and several clinical features 
in animals are similar to humans [20].
Absorption of streptolysin-O by lipid & 
polymeric systems
This assay tested ovine nanosponge and its components 
for toxin adsorption. The 2% (v/v) ghost suspension 
was examined by scanning electron microscopy and it 
showed the presence of ghosts (Supplementary Figure 3). 
The 2% (v/v) ghost suspension absorbed most strepto-
lysin-O, as the concentration of Hb released was the 
lowest compared with the other systems (Figure 5A). 
Recently published studies showed that production of 
erythrocyte ghosts does not lead to the loss of lipids 
and cholesterol from the membrane [11]. The scanning 
electron micrograph (Supplementary Figure 3) shows 
morphologically intact erythrocyte ghosts, which 
could signify that cholesterol was present in the 
membrane. This result may be further understood as 
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the erythrocyte ghosts, according to Figure 5A, have 
adsorbed streptolysin-O. Thus, it indicates that cho-
lesterol may be present in the membrane. However, 
this could be tested by measuring the concentration of 
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Figure 5. Testing absorption of 1230 ng/ml streptolysin-O by different lipid and polymeric systems, which make up the nanosponge 
(see facing page). (A) Testing the efficacy of ovine erythrocyte ghosts as a toxin-absorbing system, incubated at 37°C. The 
erythrocyte ghosts were made from 1 ml of whole blood. (B) Testing the nanosponge (1 mg/ml) and its components for absorption 
of streptolysin-O, incubated at 37°C for 30 min. (C) Testing the nanosponge (1 mg/ml) and its components for absorption of 
streptolysin-O, incubated at 37 and 40°C (human body temperature during sepsis) for 30 min. (D) Testing reconstituted nanosponge 
(1 mg/ml) and its components for absorption of streptolysin-O, incubated at 40°C. Error bars represent standard error of mean 
(n = 3). 
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
Figure 6. Concentrations at which, nanosponges can adsorb 1230 ng/ml streptolysin-O. Increasing concentrations 
of ovine nanosponges were added to 1230 ng/ml streptolysin-O and incubated at 40°C for 30 min. Error bars 
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cholesterol present in the membrane of ovine erythro-
cytes and ghosts, by using a cholesterol esterase colo-
rimetric assay [21]. This statement is further enhanced 
as nanosponges in Figure 5B have managed to adsorb 
streptolysin-O. This could mean that during synthesis 
of the nanosponge, cholesterol was not lost.
Fusion of ovine erythrocyte vesicles and the PLGA 
polymer developed ovine nanosponges. Figure 5B 
showed the efficacy of the nanosponge and its compo-
nents to adsorb streptolysin-O. The system containing 
the nanosponges had the least Hb release compared 
with the system containing just the toxin and erythro-
cytes. The ovine erythrocyte vesicles were also able to 
absorb streptolysin-O as they had nearly half the Hb 
release, as opposed to the system containing just toxin 
and erythrocytes. This could be due to the surface area 
to volume ratio, as the nanosponges have a greater sur-
face area to volume ratio (Supplementary Figure 6) [17]. 
Moreover, a published study suggests that due to the 
presence of PLGA in the core, it has the ability to lock 
the toxin compared with erythrocyte vesicles [9].
The same study was conducted at 40°C which is 
an estimation of the elevated body temperature dur-
ing sepsis [14]. Figure 5C showed that there was no dif-
ference in the concentration of Hb released by three 
of the systems, incubated at 37 and 40°C. Incubated 
at 40°C, the system that contained the nanosponges 
had adsorbed the streptolysin-O as there was no Hb 
released compared with the system at 37°C. This may 
indicate that the nanosponges have a better absorp-
tion efficiency at 40°C. This could be justified as the 
physiological body temperature of sheep is 39°C [22]. 
This may also highlight the reason for statistical sig-
nificance between the systems that contained vesicles 
(Figure 3C).
A similar study was conducted with reconsti-
tuted nanosponges and similar results were obtained. 
Figure 5D showed that ovine nanosponges had adsorbed 
all the streptolysin-O as there was no Hb released. 
This also showed that nanosponges have the ability to 
adsorb toxins after a week of being in a freeze-dried 
state. This may suggest that the nanosponges are fairly 
stable in a lyophilized state. A dose-dependent study 
was conducted to identify the concentration required 
to adsorb streptolysin-O at 40°C. Figure 6 indicated 
that 10,000 ng/ml ovine nanosponges completely 
adsorb streptolysin-O, as there was no Hb released.
Conclusion
Ovine erythrocytes and erythrocyte ghosts are sus-
ceptible to streptolysin-O hemolysis, thereby making 
sheep an appropriate model to develop nanosponges. 
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Fusion of the erythrocyte vesicles with PLGA poly-
mer forms the basis for a biomimetic nanosponge. 
This process is achieved by extrusion, which develops 
monodispersed nanosponges. Ovine nanosponges have 
the ability to absorb streptolysin-O at human body 
temperature, especially under conditions that mimic 
sepsis in humans. Reconstituted nanosponges from a 
lyophilized state retain their ability to adsorb strepto-
lysin-O. The results obtained from this study identify 
ovine nanosponges as a potential novel therapeutic 
model to test the absorption of cholesterol-binding 
toxins. Further work is required to understand the role 
that PLGA plays in adsorption; moreover, specificity 
for toxin absorption could be increased by addition of 
external cholesterol into the membrane.
Future perspective
The use of cellular membranes as biomimetic thera-
peutic agent is a novel field of nanomedicine. Current 
research has shown that the field is limited to erythro-
cyte membranes. Over 5–10 years, the field may evolve 
to stable biomimetic formulations, such as platelets 
or white blood cell membranes for drug delivery and 
toxin adsorption. This biomimetic platform may also 
evolve into a diagnostic tool to test the presence of 
 exotoxins in bodily fluids.
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Executive summary
Sonication followed by extrusion develops monodispersed nanoparticles
•	 Ovine erythrocyte vesicles were formed by sonication followed by extrusion, which produced monodispersed 
suspensions of ovine erythrocyte vesicles.
Hemolysis of different species of animal blood
•	 Ovine, porcine, murine and leporine blood showed that they were susceptible to streptolysin-O attack, 
measured by the concentration of hemoglobin released.
•	 Ovine erythrocytes were shown to be more specific for streptolysin-O binding, as the toxin was able to lyse 
ovine erythrocytes, which lead to the highest concentration of hemoglobin being released.
Ovine nanosponge form a good therapeutic model to test absorption of streptolysin-O
•	 Hemolysis assays identified ovine erythrocyte vesicles as an excellent lipid system to test toxin adsorption.
•	 Fusion of ovine erythrocyte vesicles with poly(d,l-lactic-co-glycolic acid) developed ovine nanosponges, which 
had the ability to adsorb streptolysin-O at human body temperature and in temperature conditions that mimic 
sepsis in humans.
•	 Reconstituted nanosponges from a lyophilized state retain their ability to adsorb streptolysin-O.
Dose-dependent assay
•	 Ovine nanosponges at a concentration of 10,000 ng/ml were able to adsorb 1230 ng/ml streptolysin-O.
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